ZNF557 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.390400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.437600E-01
Normal-vs-Stage2
2.885800E-02
Normal-vs-Stage3
8.171600E-02
Normal-vs-Stage4
1.885630E-01
Stage1-vs-Stage2
1.416160E-01
Stage1-vs-Stage3
1.087410E-01
Stage1-vs-Stage4
4.620800E-01
Stage2-vs-Stage3
2.659600E-01
Stage2-vs-Stage4
7.511800E-01
Stage3-vs-Stage4
2.118800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.775600E-02
Normal-vs-AfricanAmerican
1.713360E-01
Normal-vs-Asian
2.697600E-02
Caucasian-vs-AfricanAmerican
8.021200E-01
Caucasian-vs-Asian
8.573000E-01
AfricanAmerican-vs-Asian
6.635000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.928200E-02
Normal-vs-Female
3.705800E-02
Male-vs-Female
6.015800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.207800E-01
Normal-vs-Age(41-60Yrs)
7.614300E-02
Normal-vs-Age(61-80Yrs)
2.715800E-02
Normal-vs-Age(81-100Yrs)
1.751010E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.770100E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.384300E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.360480E-04
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.360000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.540460E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.861700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.490240E-02
Normal-vs-Daily Drinker
3.129500E-02
Normal-vs-Weekly Drinker
7.437800E-02
Normal-vs-Occasional Drinker
9.537900E-02
Normal-vs-Social Drinker
2.404000E-01
Non Drinker-vs-Daily Drinker
9.356200E-01
Non Drinker-vs-Weekly Drinker
1.569160E-01
Non Drinker-vs-Occasional Drinker
1.381230E-01
Non Drinker-vs-Social Drinker
7.550100E-02
Daily Drinker-vs-Weekly Drinker
2.279600E-01
Daily Drinker-vs-Occasional Drinker
2.086400E-01
Daily Drinker-vs-Social Drinker
1.271180E-01
Weekly Drinker-vs-Occasional Drinker
9.877200E-01
Weekly Drinker-vs-Social Drinker
6.531400E-01
Occasional Drinker-vs-Social Drinker
6.552400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.402050E-01
Normal-vs-Grade 2
1.001780E-01
Normal-vs-Grade 3
1.506820E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.566000E-01
Grade 1-vs-Grade 3
1.239240E-01
Grade 1-vs-Grade 4
1.402050E-01
Grade 2-vs-Grade 3
1.688630E-01
Grade 2-vs-Grade 4
1.001780E-01
Grade 3-vs-Grade 4
1.506820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.261500E-02
Normal-vs-NonDiabetic
3.428300E-02
Diabetic-vs-NonDiabetic
1.590640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.900490E-02
Normal-vs-NoPancreatitis
3.540200E-02
Pancreatitis-vs-NoPancreatitis
2.990200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.946000E-02
Normal-vs-N1
3.232100E-02
N0-vs-N1
8.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.288300E-02
Normal-vs-TP53-NonMutant
2.622400E-01
TP53-Mutant-vs-TP53-NonMutant
7.755500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
